Skip to main content

Advertisement

SpringerLink
Log in

Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

The genetic variants play a crucial role in the pathogenesis of Alzheimer’s disease (AD), while the relationships of specific single nucleotide polymorphisms (SNPs) with AD are still controversial. We performed the meta-analysis to obtain a more precise estimation of whether growth factor receptor-bound protein-associated binding protein 2 (GAB2), phosphatidylinositol binding clathrin assembly protein (PICALM), and sortilin-related receptor (SORL1) variants are associated with AD. Databases including PubMed, Embase, and Cochrane Library were searched to find relevant studies. Cochran’s Q-statistic and I 2 were used to assess the heterogeneity among the included studies. Odds ratios (OR) and 95 % confidence intervals (95 % CIs) were conducted to evaluate the association between the SNP and the susceptibility to AD. Publication bias was estimated by funnel plots. All of the statistical analyses were implemented using R Version 3.2.1 software. A total of 35 case-control studies involving 15 SNPs were included. There was no significant association between SNPs of GAB2 rs2373115 (G > T) and PICALM rs541458 (C > T) and AD. The allele T of rs3851179 in PICALM was associated with a 13 % increase in the risk of AD. Seven SNPs on SORL1 were significantly associated with AD. Four SNPs, including rs1010159*T, rs641120*A, rs668387*T, and rs689021*A, were associated with a decreased risk of AD, while the other three SNPs, including rs12285364*T, rs2070045*G, and rs2282649*T, were all associated with an increased risk of AD. The results of the present study suggested that multiple gene variants were associated with AD. The SNP of rs3851179 (PICALM), rs12285364 (SORL1), rs2070045 (SORL1), and rs2282649 (SORL1) was associated with an increased risk of AD, whereas SORL1 rs1010159, rs641120, rs668387, and rs689021 were associated with a decreased risk of AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Bagyinszky E, Youn YC, An SS, Kim S (2014) The genetics of Alzheimer’s disease. Clin Interv Aging 9:535–551

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA (2003) Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 60(8):1119–1122

    Article  PubMed  Google Scholar 

  3. Scarabino D, Gambina G, Broggio E, Pelliccia F, Corbo RM (2015) Influence of family history of dementia in the development and progression of late-onset Alzheimer’s disease. Am J Med Genet B Neuropsychiatr Genet. doi:10.1002/ajmg.b.32399

  4. Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer’s disease: a review of progress. J Neurol Neurosurg Psychiatry 66(2):137–147

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Mudher A, Lovestone S (2002) Alzheimer’s disease—do tauists and baptists finally shake hands? Trends Neurosci 25(1):22–26

    Article  CAS  PubMed  Google Scholar 

  6. Goedert M, Spillantini MG, Crowther RA (1991) Tau proteins and neurofibrillary degeneration. Brain Pathol 1(4):279–286

    Article  CAS  PubMed  Google Scholar 

  7. Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739(2–3):198–210

    Article  CAS  PubMed  Google Scholar 

  8. Chun W, Johnson GV (2007) The role of tau phosphorylation and cleavage in neuronal cell death. Front Biosci 12:733–756

    Article  CAS  PubMed  Google Scholar 

  9. Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ, Craig DW, Coon KD, Liang WS, Herbert RH, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, Kaleem M, Mastroeni D, Grover A, Heward CB, Ravid R, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Kukull W, Papassotiropoulos A, Stephan DA (2007) GAB2 alleles modify Alzheimer’s risk in APOE epsilon4 carriers. Neuron 54(5):713–720

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol Sci 12(10):383–388

    Article  CAS  PubMed  Google Scholar 

  11. Zhao Z, Sagare AP, Ma Q, Halliday MR, Kong P, Kisler K, Winkler EA, Ramanathan A, Kanekiyo T, Bu G, Owens NC, Rege SV, Si G, Ahuja A, Zhu D, Miller CA, Schneider JA, Maeda M, Maeda T, Sugawara T, Ichida JK, Zlokovic BV (2015) Central role for PICALM in amyloid-beta blood-brain barrier transcytosis and clearance. Nat Neurosci 18(7):978–987

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Xiao Q, Gil SC, Yan P, Wang Y, Han S, Gonzales E, Perez R, Cirrito JR, Lee JM (2012) Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis. J Biol Chem 287(25):21279–21289

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin CT, Cheng R, Hasegawa H, Chen F, Shibata N, Lunetta KL, Pardossi-Piquard R, Bohm C, Wakutani Y, Cupples LA, Cuenco KT, Green RC, Pinessi L, Rainero I, Sorbi S, Bruni A, Duara R, Friedland RP, Inzelberg R, Hampe W, Bujo H, Song YQ, Andersen OM, Willnow TE, Graff-Radford N, Petersen RC, Dickson D, Der SD, Fraser PE, Schmitt-Ulms G, Younkin S, Mayeux R, Farrer LA, St George-Hyslop P (2007) The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 39(2):168–177

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Meng Y, Lee JH, Cheng R, St George-Hyslop P, Mayeux R, Farrer LA (2007) Association between SORL1 and Alzheimer’s disease in a genome-wide study. Neuroreport 18(17):1761–1764

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Bowden J, Tierney JF, Copas AJ, Burdett S (2011) Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol 11:41

    Article  PubMed  PubMed Central  Google Scholar 

  16. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295(6):676–680

    Article  CAS  PubMed  Google Scholar 

  17. Zhang F, Liu X, Wang B, Cheng Z, Zhao X, Zhu J, Wang D, Wang Y, Dong A, Li P, Jin C (2015) An exploratory study of the association between SORL1 polymorphisms and sporadic Alzheimer’s disease in the Han Chinese population. Neuropsychiatr Dis Treat 11:1443–1448

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Wang HZ, Bi R, Hu QX, Xiang Q, Zhang C, Zhang DF, Zhang W, Ma X, Guo W, Deng W, Zhao L, Ni P, Li M, Fang Y, Li T, Yao YG (2014) Validating GWAS-identified risk loci for Alzheimer’s disease in Han Chinese populations. Mol Neurobiol. doi:10.1007/s12035-014-9015-z

  19. Feng X, Hou D, Deng Y, Li W, Tian M, Yu Z (2015) SORL1 gene polymorphism association with late-onset Alzheimer’s disease. Neurosci Lett 584:382–389

    Article  CAS  PubMed  Google Scholar 

  20. Wen Y, Miyashita A, Kitamura N, Tsukie T, Saito Y, Hatsuta H, Murayama S, Kakita A, Takahashi H, Akatsu H, Yamamoto T, Kosaka K, Yamaguchi H, Akazawa K, Ihara Y, Kuwano R (2013) SORL1 is genetically associated with neuropathologically characterized late-onset Alzheimer’s disease. J Alzheimers Dis 35(2):387–394

    CAS  PubMed  Google Scholar 

  21. Ohara T, Ninomiya T, Hirakawa Y, Ashikawa K, Monji A, Kiyohara Y, Kanba S, Kubo M (2012) Association study of susceptibility genes for late-onset Alzheimer’s disease in the Japanese population. Psychiatr Genet 22(6):290–293

    Article  CAS  PubMed  Google Scholar 

  22. Chen LH, Kao PY, Fan YH, Ho DT, Chan CS, Yik PY, Ha JC, Chu LW, Song YQ (2012) Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer’s disease in a southern Chinese population. Neurobiol Aging 33(1):210 e211–217

    Article  Google Scholar 

  23. Piaceri I, Bagnoli S, Lucenteforte E, Mancuso M, Tedde A, Siciliano G, Piacentini S, Bracco L, Sorbi S, Nacmias B (2011) Implication of a genetic variant at PICALM in Alzheimer’s disease patients and centenarians. J Alzheimers Dis 24(3):409–413

    PubMed  Google Scholar 

  24. Wang G, Pan XL, Cui PJ, Wang Y, Ma JF, Ren RJ, Deng YL, Xu W, Tang HD, Chen SD (2011) Association study of the GAB2 gene with the risk of Alzheimer disease in the Chinese population. Alzheimer Dis Assoc Disord 25(3):283–285

  25. Lambert JC, Zelenika D, Hiltunen M, Chouraki V, Combarros O, Bullido MJ, Tognoni G, Fievet N, Boland A, Arosio B, Coto E, Del Zompo M, Mateo I, Frank-Garcia A, Helisalmi S, Porcellini E, Pilotto A, Forti P, Ferri R, Delepine M, Scarpini E, Siciliano G, Solfrizzi V, Sorbi S, Spalletta G, Ravaglia G, Valdivieso F, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Licastro F, Lathrop M, Soininen H, Amouyel P (2011) Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol Aging 32(4):756 e711–755

    Article  Google Scholar 

  26. Yu JT, Song JH, Ma T, Zhang W, Yu NN, Xuan SY, Tan L (2011) Genetic association of PICALM polymorphisms with Alzheimer’s disease in Han Chinese. J Neurol Sci 300(1–2):78–80

    Article  CAS  PubMed  Google Scholar 

  27. Ning M, Yang Y, Zhang Z, Chen Z, Zhao T, Zhang D, Zhou D, Xu J, Liu Z, Wang Y, Liu Y, Zhao X, Li W, Li S, He L (2010) Amyloid-beta-related genes SORL1 and ACE are genetically associated with risk for late-onset Alzheimer disease in the Chinese population. Alzheimer Dis Assoc Disord 24(4):390–396

    Article  CAS  PubMed  Google Scholar 

  28. Kamboh MI, Minster RL, Demirci FY, Ganguli M, Dekosky ST, Lopez OL, Barmada MM (2012) Association of CLU and PICALM variants with Alzheimer’s disease. Neurobiol Aging 33(3):518–521

    Article  CAS  PubMed  Google Scholar 

  29. Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, Nalls MA, Chen K, Lee W, Chewning K, Villa SE, Meechoovet HB, Gerber JD, Frost D, Benson HL, O’Reilly S, Chibnik LB, Shulman JM, Singleton AB, Craig DW, Van Keuren-Jensen KR, Dunckley T, Bennett DA, De Jager PL, Heward C, Hardy J, Reiman EM, Huentelman MJ (2010) Association of CR1, CLU and PICALM with Alzheimer’s disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet 19(16):3295–3301

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Zhou S, Wang J, Huriletemuer, Wang B, Zhao S, de Wang S, Zhang C, Ma X (2010) Association analysis between polymorphism rs2373115 of gene GRB-associated binding protein 2 and Mongolian Alzheimer patients. Neurosci Lett 480(1):4–6

    Article  CAS  PubMed  Google Scholar 

  31. Lin K, Tang M, Han H, Guo Y, Lin Y, Ma C (2010) GAB2 is not associated with late-onset Alzheimer’s disease in Chinese Han. Neurol Sci 31(3):277–281

    Article  PubMed  Google Scholar 

  32. Cousin E, Mace S, Rocher C, Dib C, Muzard G, Hannequin D, Pradier L, Deleuze JF, Genin E, Brice A, Campion D (2011) No replication of genetic association between candidate polymorphisms and Alzheimer’s disease. Neurobiol Aging 32(8):1443–1451

    Article  CAS  PubMed  Google Scholar 

  33. Cellini E, Tedde A, Bagnoli S, Pradella S, Piacentini S, Sorbi S, Nacmias B (2009) Implication of sex and SORL1 variants in Italian patients with Alzheimer disease. Arch Neurol 66(10):1260–1266

    Article  PubMed  Google Scholar 

  34. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, Heun R, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O’Donovan M, Owen MJ, Williams J (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet 41(10):1088–1093

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Reynolds CA, Hong MG, Eriksson UK, Blennow K, Johansson B, Malmberg B, Berg S, Gatz M, Pedersen NL, Bennet AM, Prince JA (2010) Sequence variation in SORL1 and dementia risk in Swedes. Neurogenetics 11(1):139–142

    Article  CAS  PubMed  Google Scholar 

  36. Kimura R, Yamamoto M, Morihara T, Akatsu H, Kudo T, Kamino K, Takeda M (2009) SORL1 is genetically associated with Alzheimer disease in a Japanese population. Neurosci Lett 461(2):177–180

    Article  CAS  PubMed  Google Scholar 

  37. Kolsch H, Jessen F, Wiltfang J, Lewczuk P, Dichgans M, Teipel SJ, Kornhuber J, Frolich L, Heuser I, Peters O, Wiese B, Kaduszkiewicz H, van den Bussche H, Hull M, Kurz A, Ruther E, Henn FA, Maier W (2009) Association of SORL1 gene variants with Alzheimer’s disease. Brain Res 1264:1–6

    Article  PubMed  Google Scholar 

  38. Nacmias B, Tedde A, Bagnoli S, Cellini E, Guarnieri BM, Piacentini S, Sorbi S (2009) Implication of GAB2 gene polymorphism in Italian patients with Alzheimer’s disease. J Alzheimers Dis 16(3):513–515

    Article  CAS  PubMed  Google Scholar 

  39. Feulner TM, Laws SM, Friedrich P, Wagenpfeil S, Wurst SH, Riehle C, Kuhn KA, Krawczak M, Schreiber S, Nikolaus S, Forstl H, Kurz A, Riemenschneider M (2010) Examination of the current top candidate genes for AD in a genome-wide association study. Mol Psychiatry 15(7):756–766

    Article  CAS  PubMed  Google Scholar 

  40. Sleegers K, Bettens K, Brouwers N, Engelborghs S, van Miegroet H, De Deyn PP, Van Broeckhoven C (2009) Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementia. Hum Mutat 30(2):E338–344

    Article  PubMed  Google Scholar 

  41. Shibata N, Ohnuma T, Baba H, Higashi S, Nishioka K, Arai H (2008) Genetic association between SORL1 polymorphisms and Alzheimer’s disease in a Japanese population. Dement Geriatr Cogn Disord 26(2):161–164

    Article  CAS  PubMed  Google Scholar 

  42. Minster RL, DeKosky ST, Kamboh MI (2008) No association of SORL1 SNPs with Alzheimer’s disease. Neurosci Lett 440(2):190–192

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Chapuis J, Hannequin D, Pasquier F, Bentham P, Brice A, Leber I, Frebourg T, Deleuze JF, Cousin E, Thaker U, Amouyel P, Mann D, Lendon C, Campion D, Lambert JC (2008) Association study of the GAB2 gene with the risk of developing Alzheimer’s disease. Neurobiol Dis 30(1):103–106

    Article  CAS  PubMed  Google Scholar 

  44. Lee JH, Cheng R, Honig LS, Vonsattel JP, Clark L, Mayeux R (2008) Association between genetic variants in SORL1 and autopsy-confirmed Alzheimer disease. Neurology 70(11):887–889

    Article  CAS  PubMed  Google Scholar 

  45. Li Y, Rowland C, Catanese J, Morris J, Lovestone S, O’Donovan MC, Goate A, Owen M, Williams J, Grupe A (2008) SORL1 variants and risk of late-onset Alzheimer’s disease. Neurobiol Dis 29(2):293–296

    Article  PubMed  Google Scholar 

  46. Lee JH, Cheng R, Schupf N, Manly J, Lantigua R, Stern Y, Rogaeva E, Wakutani Y, Farrer L, St George-Hyslop P, Mayeux R (2007) The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol 64(4):501–506

    Article  PubMed  PubMed Central  Google Scholar 

  47. Klimkowicz-Mrowiec A, Sado M, Dziubek A, Dziedzic T, Pera J, Szczudlik A, Słowik A (2013). Lack of association of CR1, PICALM and CLU gene polymorphisms with Alzheimer disease in a Polish population. Neurol Neurochir Pol 47(2):157–160

  48. Ramirez-Lorca R, Boada M, Saez ME, Hernandez I, Mauleon A, Rosende-Roca M, Martinez-Lage P, Gutierrez M, Real LM, Lopez-Arrieta J, Gayan J, Antunez C, Gonzalez-Perez A, Tarraga L, Ruiz A (2009) GAB2 gene does not modify the risk of Alzheimer’s disease in Spanish APOE 4 carriers. J Nutr Health Aging 13(3):214–219

  49. Olgiati P, Politis A, Albani D, Rodilossi S, Polito L, Ateri E, Zisaki A, Piperi C, Liappas I, Stamouli E, Mailis A, Atti AR, Ferrari B, Morini V, Moretti F, Biella G, Forloni G, Papadimitriou GN, Ronchi DD, Kalofoutis A, Serretti A (2012) Association of SORL1 alleles with late-onset Alzheimer’s disease. Findings from the GIGAS_LOAD study and mega-analysis. Curr Alzheimer Res 9(4):491–499

  50. Izzo G, Forlenza OV, Santos B, Bertolucci PH, Ojopi EB, Gattaz WF, Kerr DS (2013) Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer’s disease: interactions with the APOE genotype. Clinics 68(2):277–280

    Article  PubMed  PubMed Central  Google Scholar 

  51. Parikh I, Fardo DW, Estus S (2014) Genetics of PICALM expression and Alzheimer’s disease. PLoS One 9(3), e91242

    Article  PubMed  PubMed Central  Google Scholar 

  52. Young JE, Boulanger-Weill J, Williams DA, Woodruff G, Buen F, Revilla AC, Herrera C, Israel MA, Yuan SH, Edland SD, Goldstein LS (2015) Elucidating molecular phenotypes caused by the SORL1 Alzheimer’s disease genetic risk factor using human induced pluripotent stem cells. Cell Stem Cell 16(4):373–385

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Louwersheimer E, Ramirez A, Cruchaga C, Becker T, Kornhuber J, Peters O, Heilmann S, Wiltfang J, Jessen F, Visser PJ, Scheltens P, Pijnenburg YA, Teunissen CE, Barkhof F, van Swieten JC, Holstege H, Van der Flier WM, Alzheimer’s Disease Neuroimaging I, Dementia Competence N (2015) The influence of genetic variants in SORL1 gene on the manifestation of Alzheimer’s disease. Neurobiol Aging 36(3):1605 e1613–1620

    Article  Google Scholar 

  54. Caglayan S, Bauerfeind A, Schmidt V, Carlo AS, Prabakaran T, Hubner N, Willnow TE (2012) Identification of Alzheimer disease risk genotype that predicts efficiency of SORL1 expression in the brain. Arch Neurol 69(3):373–379

    Article  PubMed  Google Scholar 

  55. Alexopoulos P, Guo LH, Kratzer M, Westerteicher C, Kurz A, Perneczky R (2011) Impact of SORL1 single nucleotide polymorphisms on Alzheimer’s disease cerebrospinal fluid markers. Dement Geriatr Cogn Disord 32(3):164–170

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Ganzer S, Arlt S, Schoder V, Buhmann C, Mandelkow EM, Finckh U, Beisiegel U, Naber D, Muller-Thomsen T (2003) CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer’s disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity. J Neural Transm (Vienna) 110(10):1149–1160

    Article  CAS  Google Scholar 

  57. Kolsch H, Jessen F, Wiltfang J, Lewczuk P, Dichgans M, Kornhuber J, Frolich L, Heuser I, Peters O, Schulz JB, Schwab SG, Maier W (2008) Influence of SORL1 gene variants: association with CSF amyloid-beta products in probable Alzheimer’s disease. Neurosci Lett 440(1):68–71

    Article  PubMed  Google Scholar 

  58. Elias-Sonnenschein LS, Bertram L, Visser PJ (2012) Relationship between genetic risk factors and markers for Alzheimer’s disease pathology. Biomark Med 6(4):477–495

  59. Olgiati P, Politis A, Albani D, Rodilossi S, Polito L, Zisaki A, Piperi C, Liappas I, Stamouli E, Mailis A, Batelli S, Forloni G, Marsano A, Balestri M, Soldatos CR, De Ronchi D, Kalofoutis A, Serretti A (2013) Effects of SORL1 gene on Alzheimer’s disease. Focus on gender, neuropsychiatric symptoms and pro-inflammatory cytokines. Curr Alzheimer Res 10(2):154–164

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

  1. Emergency Department, Linyi People’s Hospital, Linyi, 276003, Shandong, China

    Ziran Wang, Hongyan Lei, Mei Zheng, Yuxin Li & Yansen Cui

  2. Department of Neurology, Liaocheng People’s Hospital, No.67 Dongchangxi Road, Liaocheng, 252000, Shandong, China

    Fang Hao

Authors
  1. Ziran Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hongyan Lei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mei Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuxin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yansen Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fang Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fang Hao.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 40 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Z., Lei, H., Zheng, M. et al. Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1 . Mol Neurobiol 53, 6501–6510 (2016). https://doi.org/10.1007/s12035-015-9546-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-015-9546-y

Keywords

Search

Navigation